Merck KGaA (ETR:MRK)
Germany
· Delayed Price · Currency is EUR | Market Cap | 54.83B |
| Revenue (ttm) | 21.16B |
| Net Income (ttm) | 2.78B |
| Shares Out | 434.78M |
| EPS (ttm) | 6.39 |
| PE Ratio | 19.74 |
| Forward PE | 13.58 |
| Dividend | 2.20 (1.74%) |
| Ex-Dividend Date | Apr 28, 2025 |
| Volume | 186,361 |
| Average Volume | 354,399 |
| Open | 125.00 |
| Previous Close | 126.10 |
| Day's Range | 122.95 - 126.70 |
| 52-Week Range | 122.95 - 177.00 |
| Beta | 0.74 |
| RSI | 34.06 |
| Earnings Date | Mar 6, 2025 |
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a... [Read more]
Financial Performance
In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.
Financial StatementsNews
Zebra Technologies and Merck KGaA, Darmstadt, Germany Collaborate to Create Safety and Traceability Solutions
Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitising and automating frontline workflows, and Merck KGaA, Darmstadt, Germany, a leading science and technology company, today ann...
EQS-DD: Merck KGaA: Freifrau Helene von Roeder, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.03.2025 / 16:24 CET/CEST The issuer is solely responsi...
EQS-DD: Merck KGaA: Peter Guenter, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.03.2025 / 16:16 CET/CEST The issuer is solely responsi...
EQS-DD: Merck KGaA: Dr. Matthias Heinzel, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.03.2025 / 16:09 CET/CEST The issuer is solely responsi...
EQS-DD: Merck KGaA: Belén Garijo Lopez, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 27.03.2025 / 15:59 CET/CEST The issuer is solely responsi...
Merck KGaA: Still A Bit Too Expensive
Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free cash flow yield. Read why MKGAF is a hold.
Merck KGaA (MKGAF) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...
Merck KGaA (MKGAF) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic Investments Propel Performance
Resilience is part of our DNA, says Merck KGaA CEO
Belén Garijo, CEO of Merck KGaA, said the German pharmaceutical company has increased its readiness to deal with the ongoing geopolitical uncertainty, and is confident it will continue delivering prof...
Merck KGaA (MKGAF) Q4 2024 Earnings Call Transcript
Resilience is part of our DNA, says Merck KGaA CEO
Beln Garijo, CEO of Merck KGaA, said the German pharmaceutical company has increased its readiness to deal with the ongoing geopolitical uncertainty, and is confident it will continue delivering profi...
Merck KGaA Sees Profit Growth in 2025 as Recovery Takes Hold
Merck KGaA forecast rising profit this year as its life science business continues to recover and the boom in AI lifts demand at its semiconductor division.
Merck KGaA Non-GAAP EPS of €8.63, revenue of €21.16B; initiates FY25 outlook
Merck KGaA press release (MKGAF): FY Non-GAAP EPS of €8.63. Revenue of €21.16B (+0.8% Y/Y) (organically: +2.0%). EBITDA pre rose to € 6.1 billion (organically: +6.9%). Stable dividend
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
Merck KGaA sees forex-adjusted earnings growth of up to 8% this year
Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug production.
Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors
Wiley (NYSE: WLY), one of the world’s largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...
Merck KGaA to replace two executives with company veterans
Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but it added that its strategy remains unchanged.
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
Merck KGaA is in advanced talks to ... Full story available on Benzinga.com
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2197498817-f6415a8260e84c978dab4966d8195b9a.jpg)
SpringWorks Stock Jumps More Than 30% on News of Possible Deal
SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.
Crude Oil Rises Sharply; Manhattan Associates Shares Slide
U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 150 points on Monday. The Dow traded up 0.40% to 44,482.54 while the NASDAQ gained 1.16% to 19,750.22. T...
EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition 10-Feb-2025 / 20:06 CET/CEST Disclosure of an in...
Rockwell Automation Posts Upbeat Earnings, Joins Insperity, BP, Alibaba And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Nasdaq Composite gaining around 200 points on Monday. Shares of Rockwell Automation, Inc. (NYSE: ROK) rose sharply during Monday's session after the company reported...
SpringWorks Therapeutics jumps on report of Merck KGaA takeover talks
Exclusive: Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
Merck KGaA , the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics , according to people familiar with the matter...
Merck KGaA says high asset prices call for prudent M&A approach
The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.
MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
Custom robotic workstation automates company’s broad portfolio of biology assays for academia, biotech, and pharma Meets growing need for autonomous tools that boost throughput and reproducibility Pro...